Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
AstraZeneca, Durvalumab
AstraZeneca Pharma receives nod for cancer drug Durvalumab; stock soars 12%
The uptick in AstraZeneca share price came after the company announced that it has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL sol from CDSO.
AstraZeneca Pharma shares rally 13%, hit 52-week high after receiving nod for cancer drug Durvalumab
The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages (SMAs).
AstraZeneca Pharma gets nod to sell immunotherapy drug Durvalumab; stock surges
This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.
AstraZeneca shares rally 13%, hit record high as firm gets nod for cancer drug
Astrazeneca Pharma India has received CDSO's (Central Drugs Standard Control Organisation) nod for the import of Durvalumab for its sale and distribution.
Lung cancer drug: AstraZeneca India wins CDSCO nod for Durvalumab for specified additional indication
Bengaluru: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion from the Central
AstraZeneca Pharma Gets Approval To Import And Distribute Durvalumab For Cancer Treatment
This approval allows Durvalumab to be used together with chemotherapy before surgery, and then as a single treatment afterward.
AstraZeneca Pharma Surges on CDSO Approval for Durvalumab in India
AstraZeneca Pharma India has received approval from the CDSO for the import, sale, and distribution of Durvalumab.
AstraZeneca India gets CDSCO nod for its chemotherapy drug additional indications
According to GLOBOCAN 2022 data, lung cancer remains the fourth most common cause of cancer-related mortality in India.
AstraZeneca Stock Falls After Disappointing Results in Breast Cancer Drug Trial
Key Takeaways A breast cancer drug being developed by AstraZeneca failed to "achieve statistical significance" in helping patients live longer than with chemotherapy in a phase 3 trial.The trial included over 700 patients with inoperable or metastatic breast cancer.
AstraZeneca Pharma gets nod to launch cancer drug durvalumab in India
The approved indication involves using durvalumab in combination with chemotherapy as a neoadjuvant treatment, followed by durvalumab monotherapy post-surgery. Shares of Astrazeneca Pharma India Ltd ended at ₹6,
Cure Today
7h
Imfinzi Improves Survival Outcomes in Subgroups of Patients with LS-SCLC
Among patients with limited-stage small cell lung cancer, the benefits of consolidation Imfinzi were seen across a number of ...
Medscape
7d
'One of the Most Impactful' ESMO Studies: Durvalumab in Muscle-Invasive Bladder Cancer
BARCELONA — Adding the immune checkpoint inhibitor durvalumab to standard treatment for muscle-invasive bladder cancer (MIBC) ...
oncnursingnews
11d
Postsurgical Durvalumab Does Not Boost DFS in Lung Cancer
Adjuvant durvalumab failed to improve disease-free survival in resected EGFR- or ALK-negative non-small cell lung cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Diagnosed with Parkinson's
Food packaging cancer risk
Devils Tower climber dies
Contempt charge coming?
Severe obesity on the rise
Phoenix breaks heat record
To shut down TikTok Music
Texas sues Biden admin
Outlaws guitarist dies
Didn't authorize apology
Seeks NIL compensation
OR removes 1,200+ voters
Calif. school phone ban law
Consumer confidence falls
Gold prices hit all-time high
John becomes Category 3
NY reports death from EEE
Conn. counterfeit drug bust
UAE president WH meeting
Addresses United Nations
1/3 think they have CTE
1st NL East title since 2011
Foreign incentives offer?
Russian aircraft detected
Retiring after 14 seasons
Study about oceans' acidity
California sues ExxonMobil
DOJ sues Visa
Colo. shooter found guilty
Ammonia-powered tug sails
Closing last full-size store
Dali owner, operator sued
Partners with Google
Related topics
AstraZeneca Pharma
India
Imfinzi
ML
Feedback